What changed
📄 JUPITER NEUROSCIENCES, INC.
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on developing a proprietary formulation of resveratrol, JOTROLâ„¢, to treat rare diseases and central nervous system disorders. The company's lead product candidate targets mucopolysaccharidoses type 1, Friedreich's ataxia, and MELAS, with a Phase 2 clinical trial planned. Jupiter aims to address significant unmet medical needs by leveraging its platform to enhance the bioavailability of resveratrol.
Why it matters
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on developing a proprietary formulation of resveratrol, JOTROLâ„¢, to treat rare diseases and central nervous system disorders. The company's lead product candidate targets mucopolysaccharidoses type 1, Friedreich's ataxia, and MELAS, with a Phase 2 clinical trial planned. Jupiter aims to address significant unmet medical needs by leveraging its platform to enhance the bioavailability of resveratrol.